Jean Coutu Group PJC Inc (TSE:PJC.A) Given Consensus Recommendation of “Hold” by Analysts
Shares of Jean Coutu Group PJC Inc (TSE:PJC.A) have earned a consensus recommendation of “Hold” from the eight analysts that are currently covering the firm. One analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is C$19.31.
A number of analysts have weighed in on PJC.A shares. TD Securities restated a “reduce” rating and set a C$17.50 target price on shares of Jean Coutu Group PJC in a report on Monday, July 18th. CIBC reiterated a “sector perform” rating and set a C$19.00 price objective on shares of Jean Coutu Group PJC in a report on Wednesday, July 6th. Scotiabank reiterated a “sector perform” rating and set a C$19.00 price objective on shares of Jean Coutu Group PJC in a report on Tuesday, July 5th. Royal Bank Of Canada decreased their price objective on Jean Coutu Group PJC from C$20.00 to C$19.00 and set a “sector perform” rating for the company in a report on Wednesday, July 6th. Finally, Dundee Securities reiterated a “neutral” rating and set a C$20.00 price objective on shares of Jean Coutu Group PJC in a report on Thursday, September 22nd.
Jean Coutu Group PJC Company Profile
The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.
Receive News & Stock Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related stocks with our FREE daily email newsletter.